Chlorhexidine and Zinc in Non-Surgical Periodontal Therapy
CHX-Zn
The Effect of Chlorhexidine and Zinc as Adjuncts to Non-Surgical Periodontal Therapy in Stage I and II Periodontitis: A Randomized Controlled Clinical Trial
1 other identifier
interventional
44
1 country
1
Brief Summary
Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth and is associated with both local tissue destruction and systemic inflammatory responses. Non-surgical periodontal therapy, particularly scaling and root planing (SRP), is the primary treatment approach; however, it may not completely eliminate pathogenic microorganisms in all cases. Adjunctive antimicrobial agents may improve treatment outcomes by enhancing bacterial reduction and modulating inflammation. Chlorhexidine (CHX) is widely used for its antimicrobial properties, while zinc has anti-inflammatory and immunomodulatory effects. The combined use of CHX and zinc may provide synergistic benefits in periodontal therapy. The aim of this randomized controlled clinical trial is to evaluate the clinical and biochemical effects of CHX and zinc as adjuncts to SRP in individuals with stage I and II periodontitis. A total of 44 systemically healthy participants will be randomly assigned to two groups. The test group will receive SRP with CHX and zinc, while the control group will receive SRP with distilled water. Clinical periodontal parameters (Plaque Index, Bleeding on Probing, Probing Pocket Depth, and Clinical Attachment Level) and biochemical markers (C-reactive protein, high-sensitivity CRP, Oncostatin M, and Antistreptolysin O) will be evaluated at baseline, 1 month, and 3 months. The results of this study are expected to provide evidence regarding the potential benefits of CHX and zinc in improving periodontal treatment outcomes and reducing systemic inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 2, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedApril 22, 2026
April 1, 2026
9 months
April 2, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Probing Pocket Depth (PPD)
Measurement of periodontal pocket depth in millimeters to evaluate clinical periodontal improvement.
Baseline, 1 month, and 3 months
Clinical Attachment Level (CAL)
Assessment of clinical attachment level in millimeters as an indicator of periodontal tissue healing.
Baseline, 1 month, and 3 months
Secondary Outcomes (6)
Plaque Index (PI)
Baseline, 1 month, and 3 months
Bleeding on Probing (BOP)
Baseline, 1 month, and 3 months
C-Reactive Protein (CRP)
Baseline, 1 month, and 3 months
High-Sensitivity C-Reactive Protein (hs-CRP)
Baseline, 1 month, and 3 months
Oncostatin M (OSM)
Baseline, 1 month, and 3 months
- +1 more secondary outcomes
Study Arms (2)
Chlorhexidine-Zinc Adjunctive SRP
EXPERIMENTALParticipants receive scaling and root planing with adjunctive chlorhexidine and zinc.
SRP with Distilled Water
ACTIVE COMPARATORParticipants receive scaling and root planing (SRP) using an ultrasonic device with distilled water.
Interventions
Scaling and root planing is performed using an ultrasonic device with a solution containing chlorhexidine and zinc.
Scaling and root planing is performed using an ultrasonic device with distilled water.
Eligibility Criteria
You may qualify if:
- Individuals aged between 18 and 65 years
- Systemically healthy individuals
- Diagnosed with Stage I or Stage II periodontitis according to the 2017 classification
- Having probing pocket depth ≤5 mm and clinical attachment loss ≤4 mm
- Having a sufficient number of teeth for periodontal evaluation
- Willing to participate and able to provide informed consent
You may not qualify if:
- Presence of systemic diseases affecting periodontal health
- Pregnancy or breastfeeding
- Smoking
- Use of antibiotics or anti-inflammatory drugs within the last 6 months
- History of periodontal treatment within the last 6 months
- Fewer than 15 teeth present
- History of radiotherapy or chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University Faculty of Dentistry
Erzurum, Erzurum, Turkey (Türkiye)
Related Links
- Provides the current classification system for periodontitis (2017), which forms the basis for patient selection in this study.
- Demonstrates the clinical and microbiological benefits of adjunctive subgingival irrigation in combination with scaling and root planing in patients with chronic periodontitis.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alparslan Dilsiz, Professor
Ataturk University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The clinical outcome assessor is blinded to group allocation. The operator performing the treatment is aware of the intervention, while participants are not explicitly informed about group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 2, 2026
First Posted
April 8, 2026
Study Start
June 16, 2025
Primary Completion
March 26, 2026
Study Completion
April 1, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy and confidentiality considerations. The study involves a limited number of participants from a single center, and no formal data-sharing plan has been established.